Stocks
Medtronic Financial Statements (MDT) |
||||||||||
| Medtronicsmart-lab.ru | % | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | 2024Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.10.2023 | 30.11.2023 | 20.02.2024 | 27.02.2024 | 23.05.2024 | 23.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 7 984 | 7 984 | 8 089 | 8 589 | 24 662 | ||||
| Operating Income, bln rub | 1 340 | 1 340 | 1 483 | 1 809 | 4 632 | |||||
| EBITDA, bln rub | ? | 2 270 | 2 270 | 1 483 | 2 463 | 6 216 | ||||
| Net profit, bln rub | ? | 909.0 | 909.0 | 1 322 | 654.0 | 2 885 | ||||
| OCF, bln rub | ? | 661.0 | 661.0 | 10.8 | 2 474 | 3 146 | ||||
| CAPEX, bln rub | ? | 461.0 | 461.0 | 0.000 | 346.0 | 807.0 | ||||
| FCF, bln rub | ? | 200.0 | 200.0 | 10.8 | 2 128 | 2 339 | ||||
| Dividend payout, bln rub | 918.0 | 918.0 | 0.000 | 917.0 | 1 835 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| Dividend payout ratio, % | 101.0% | 101.0% | 69.4% | 0.00% | 63.6% | |||||
| OPEX, bln rub | 3 778 | 3 778 | 3 368 | 3 825 | 10 971 | |||||
| Cost of production, bln rub | 2 761 | 2 761 | 2 782 | 2 955 | 8 498 | |||||
| R&D, bln rub | 698.0 | 698.0 | 695.0 | 675.0 | 2 068 | |||||
| Interest expenses, bln rub | 180.0 | 180.0 | 188.0 | 202.0 | 570.0 | |||||
| Assets, bln rub | 90 087 | 90 087 | 90 836 | 90 836 | 89 981 | 89 981 | ||||
| Net Assets, bln rub | ? | 51 460 | 51 460 | 51 792 | 51 792 | 50 214 | 50 214 | |||
| Debt, bln rub | 25 080 | 25 080 | 25 182 | 25 182 | 25 024 | 25 024 | ||||
| Cash, bln rub | 7 734 | 7 734 | 1 623 | 8 321 | 8 005 | 8 005 | ||||
| Net debt, bln rub | 17 346 | 17 346 | 23 559 | 16 861 | 17 019 | 17 019 | ||||
| Ordinary share price, rub | 70.6 | 69.4 | 86.5 | 86.5 | 79.7 | 72.0 | ||||
| Number of ordinary shares, mln | 1 330 | 1 330 | 1 330 | 1 322 | 1 322 | |||||
| Market cap, bln rub | 93 859 | 92 356 | 0 | 115 072 | 105 440 | 95 206 | ||||
| EV, bln rub | ? | 111 205 | 109 702 | 23 559 | 131 933 | 122 459 | 112 225 | |||
| Book value, bln rub | -3 421 | -3 421 | -3 058 | -3 058 | -3 997 | -3 997 | ||||
| EPS, rub | ? | 0.68 | 0.68 | 0.99 | 0.49 | 2.18 | ||||
| FCF/share, rub | 0.15 | 0.15 | 1.60 | 0.00 | 1.77 | |||||
| BV/share, rub | -2.57 | -2.57 | -2.30 | -3.02 | -3.02 | |||||
| EBITDA margin, % | ? | 28.4% | 28.4% | 18.3% | 28.7% | 25.2% | ||||
| Net margin, % | ? | 11.4% | 11.4% | 16.3% | 7.61% | 11.7% | ||||
| FCF yield, % | ? | 1.54% | 1.56% | 2.20% | 2.21% | 2.46% | ||||
| ROE, % | ? | 6.61% | 6.61% | 7.59% | 8.62% | 8.38% | 5.75% | |||
| ROA, % | ? | 3.77% | 3.77% | 4.33% | 4.91% | 4.68% | 3.21% | |||
| P/E | ? | 27.6 | 27.2 | 0.00 | 25.8 | 25.1 | 33.0 | |||
| P/FCF | 469.3 | 64.0 | 0.00 | 45.5 | 45.3 | 40.7 | ||||
| P/S | ? | 2.99 | 2.94 | 0.00 | 3.58 | 3.22 | 3.86 | |||
| P/BV | ? | -27.4 | -27.0 | 0.00 | -37.6 | -26.4 | -23.8 | |||
| EV/EBITDA | ? | 12.7 | 12.5 | 2.90 | 17.6 | 15.9 | 18.1 | |||
| Debt/EBITDA | 1.98 | 1.98 | 2.90 | 2.25 | 2.21 | 2.74 | ||||
| R&D/CAPEX, % | 151.4% | 151.4% | 200.9% | 256.3% | ||||||
| CAPEX/Revenue, % | 5.77% | 5.77% | 4.28% | 0.00% | 3.27% | |||||
| Medtronic shareholders | ||||||||||
